3[4]Jaye DL,Waites KB.Clinical applications of C-reactive protein in pediatrics[J].Ped Inf Dis J,1997,16(8):735-746.
4Ridker PM,Hennekens CH,Burring JE,et al.C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women[].The New England Journal of Medicine.2000
5Feldman JG,Goldwasser P,Holman S,et al.C-reactive protein is an independent predictor of mortality in women with HIV-1infection[].JAIDS Journal of Acquired Immune Deficiency Syndromes.2003
6Melbye H,Bjorkheim MK,Leinan T.Daily reduction in C-reactive pro-tein values,symptoms,signs and temperature in group-A streptococcal pharyngitis treated with antibiotics[].Scandinavian Journal of Clinical and Laboratory Investigation.2002
7Cushman M,Legault C,Barrett-Connor E,et al.Effect of postmenopausal hormones on inflammation-sensitive -proteins: the Postmenopausel Estrogen/Progestin Interventions(PEPI)Study[].Circulation.1999
8Ridker PM,Hennekens CH,Rifai N,et al.Hormone replacement therapy and increased plasma concentration of C-reactive protein[].Circulation.1999
9Bickel C,Rupprecht HJ,Blankenberg S,et al.Relation of markers of inflammation (C-reactive protein, fibrinogen, von Willebrand factor, and leukocyte count) and statin therpy to long-term mortality in patients with anginographically proven coronary artery disease[].The American Journal of Cardiology.2002
10Biasucci LM,Liuzzo G,Grillo RL,et al.Eleavated levels of Creactive protein at discharge in patients with unsatable angina predict recurrent instability[].Circulation.1999
